Published 09/18/2024 9:35:00 a.m.

Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant

Neuralink has received “breakthrough device” clearance from the FDA for its Blindsight implant, which offers priority FDA review but does not confirm a cure for blindness.
Blindsight is a technology designed to help restore limited vision using microelectrode arrays embedded in the visual cortex.
Elon Musk claimed that Blindsight could enable those who are blind to see, although experts warn that such claims are premature.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

News18 India

Elon Musk's Neuralink Gets FDA's Breakthrough 'Device Tag' For 'Blindsight' Implant

The experimental device, known as Blindsight, will enable even those who have lost both eyes and their optic nerve to see

09/18/2024 4:21:14 a.m.·India

Read Full Article

The Hindu

Musk’s Neuralink gets FDA’s breakthrough device tag for ‘Blindsight’ implant

Musk’s chip implant startup Neuralink has received the ‘breakthrough device’ designation for its Blindsight device, he said on X.

09/18/2024 4:39:26 a.m.·India

Read Full Article

Reuters

Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant

Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation.

09/18/2024 9:35:00 a.m.·United Kingdom

Read Full Article

India Today

Elon Musk's Neuralink gets approval for 'Blindsight' device to restore vision

In his tweet, Elon Musk also said that the experimental device would "even enable those who have been blind from birth to see for the first time" provided that the visual cortex is intact.

09/18/2024 1:47:58 a.m.·India

Read Full Article